Eribulin mesylate (halichondrin B analog E7389) in platinum-resistant and platinum-sensitive ovarian cancer: a 2-cohort, phase 2 study.
about
Eribulin in Cancer TreatmentEribulin in the management of inoperable soft-tissue sarcoma: patient selection and survivalEribulin for advanced breast cancer: a drug evaluation.Potential clinical applications of halichondrins in breast cancer and other neoplasms.Eribulin mesylate in the management of metastatic breast cancer and other solid cancers: a drug review.Review on the clinical use of eribulin mesylate for the treatment of breast cancer.Axonal Transport Impairment in Chemotherapy-Induced Peripheral Neuropathy
P2860
Q26799328-73F751B3-8A21-4113-9FED-BE35F066D527Q28074125-CA05AA82-E635-4C4E-A37A-793F067DC35AQ36763961-C7D79C3C-DC23-4037-B281-A4FDCAD3D0ADQ37356164-9B2CBEE1-55A8-4F57-94D8-AC1168616FE4Q38213846-0455351E-2B79-495F-86FF-704E9685B7C0Q38711371-A5071DB1-FDA0-46B4-84E3-0F6600086D35Q42361415-5A7224AA-C643-4EED-A6F6-988737CA3C60
P2860
Eribulin mesylate (halichondrin B analog E7389) in platinum-resistant and platinum-sensitive ovarian cancer: a 2-cohort, phase 2 study.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Eribulin mesylate (halichondri ...... er: a 2-cohort, phase 2 study.
@ast
Eribulin mesylate (halichondri ...... er: a 2-cohort, phase 2 study.
@en
type
label
Eribulin mesylate (halichondri ...... er: a 2-cohort, phase 2 study.
@ast
Eribulin mesylate (halichondri ...... er: a 2-cohort, phase 2 study.
@en
prefLabel
Eribulin mesylate (halichondri ...... er: a 2-cohort, phase 2 study.
@ast
Eribulin mesylate (halichondri ...... er: a 2-cohort, phase 2 study.
@en
P2093
P2860
P356
P1433
P1476
Eribulin mesylate (halichondri ...... er: a 2-cohort, phase 2 study.
@en
P2093
Alexia Iasonos
Carol A Aghajanian
Christin Whalen
Corinne Zarwan
Lauren Pereira
Martee L Hensley
Paul Sabbatini
Sara Kravetz
Suzanne Berlin
William Tew
P2860
P304
P356
10.1002/CNCR.26569
P407
P577
2011-09-20T00:00:00Z